Data as of Apr 17
| -0.10 / -4.05%|
The 1 analysts offering 12-month price forecasts for Oragenics Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +195.36% increase from the last price of 2.37.
The current consensus among 1 polled investment analysts is to Buy stock in Oragenics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.